Recombinant vaccine for preventing and treating porcine atrophic rhinitis
US7851605B2 · kind B2 · utility
1Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2007 |
| Grant date | Dec 14, 2010 |
| Priority date | — |
| Expiry date | Jul 30, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/552
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a recombinant vaccine for porcine atrophic rhinitis. A vaccine is provided which uses a Pasteurella multocida (D:4) outer membrane protein H. The vaccine uses a small size of peptides, so that it exhibits a remarkable activity. In addition, it is possible to provide a vaccine that can be applied in the body through a variety of routes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.